Cannabis consolidation and regulatory infrastructure lead today’s brief, with a major takeover fight intensifying and New Mexico operators warning of imminent supply-chain disruption. California’s challenge to one of Hollywood’s largest proposed mergers also returned to a more confrontational footing.
Aurora Escalates Defense Against Curaleaf’s Hostile Takeover Bid
Aurora Cannabis on August 24 urged shareholders to take no action on Curaleaf Holdings’ unsolicited takeover bid, arguing that Curaleaf has made inaccurate claims about Aurora’s business and international medical-cannabis strategy. Aurora’s board and a newly formed committee of independent directors are reviewing the offer with financial and legal advisers.
Curaleaf formally launched the bid on August 18, offering stated consideration of US$4 per Aurora share through 0.3463 Curaleaf subordinate voting shares and US$0.75 in cash. The consideration is capped at US$5 per Aurora share, and Aurora said the offer must remain open for at least 105 days.
Aurora maintains that Curaleaf is attempting to acquire its European Union Good Manufacturing Practice infrastructure and global medical platform at an insufficient price. Curaleaf has argued that combining the companies would create a larger and more diversified international cannabis operator.
Why It Matters: Analysis: The contest could become an important test of consolidation appetite in the global cannabis sector, particularly for companies seeking established European medical-cannabis assets. Aurora’s special committee, shareholder response and any revised or competing proposal will determine whether the dispute develops into a prolonged proxy and tender battle.
Source: Aurora Cannabis company statement
New Mexico Cannabis Operators Seek Emergency Halt to Tracking-System Transition
Two cannabis businesses and the Cannabis Association of New Mexico filed for a temporary restraining order and preliminary injunction against state regulators, seeking to keep the BioTrack compliance platform operating while New Mexico prepares its replacement seed-to-sale system.
The transition is scheduled to begin at 5 p.m. on August 25, when BioTrack will stop processing product transfers for non-retail licensees. Testing laboratories are scheduled to stop receiving samples through August 31, the New Mexico Seed-to-Sale System is expected to launch September 1 and 2, and BioTrack is scheduled to become unavailable to retailers on September 4.
The plaintiffs allege that the timetable could interrupt testing, inventory transfers and wholesale commerce before the replacement platform has been adequately tested. They also argue that transition instructions conflict with existing state rules governing operations during a loss of track-and-trace access. The filing asks the court to preserve BioTrack as the official system while allowing continued development and parallel deployment of the replacement.
Why It Matters: Analysis: Track-and-trace platforms are core operating infrastructure in regulated cannabis markets. Even a short disruption can strand inventory, delay revenue and create compliance exposure, making the court’s response relevant well beyond New Mexico as other states modernize aging seed-to-sale systems.
Source: Second Judicial District Court filing
California Cancels Paramount-Warner Bros. Merger Mediation
California Attorney General Rob Bonta canceled a planned August 24 mediation session with Paramount Skydance over the state-led antitrust challenge to Paramount’s proposed $111-billion acquisition of Warner Bros. Discovery. Bonta accused Paramount of leaking and misrepresenting confidential settlement discussions; Paramount denied being the source of the leaks and said it remained prepared to negotiate.
California leads a coalition of 12 state attorneys general seeking to block the transaction on competition grounds. The companies previously agreed not to complete the merger until June 1, 2027, or until shortly after a court decision on the states’ claims, whichever comes first. No replacement mediation date had been announced.
Why It Matters: Analysis: The breakdown increases the likelihood that the dispute will continue toward a high-stakes antitrust trial. The outcome could reshape film distribution, cable television, streaming competition and employment across Southern California’s already pressured entertainment economy.
Source: Los Angeles Times
What We’re Watching
Over the next 24 to 72 hours, watch for emergency court action before New Mexico’s August 25 tracking-system cutoff, further guidance from Aurora’s special committee and publication of the corrected DEA marijuana-rescheduling hearing transcript by August 26. Any attempt to restart Paramount-Warner Bros. mediation also could signal whether California’s antitrust fight remains negotiable.
